4.7 Article

A Simple Reverse Transcriptase PCR Melting-Temperature Assay To Rapidly Screen for Widely Circulating SARS-CoV-2 Variants

Journal

JOURNAL OF CLINICAL MICROBIOLOGY
Volume 59, Issue 10, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00845-21

Keywords

SARS-CoV-2; variants; N501Y; E484K; melting temperature; screening test; sloppy molecular beacon

Categories

Funding

  1. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI131617]
  2. Cepheid

Ask authors/readers for more resources

A simple, rapid RT-PCR melting-temperature screening assay was developed to identify major SARS-CoV-2 variants of concern (VOCs) with high sensitivity and specificity. The assay can be used to quickly screen large numbers of patient samples, providing early warnings for the emergence of these variants and offering a simple way to track their spread.
The increased transmission of SARS-CoV-2 variants of concern (VOC), which originated in the United Kingdom (B.1.1.7/alpha), South Africa (B1.351/beta), Brazil (P.1/gamma), the United States (B.1.427/429 or epsilon), and India (B.1.617.2/ delta), requires a vigorous public health response, including real-time strain surveillance on a global scale. Although genome sequencing is the gold standard for identifying these VOCs, it is time-consuming and expensive. Here, we describe a simple, rapid, and high-throughput reverse transcriptase PCR (RT-PCR) melting-temperature (T-m) screening assay that identifies the first three major VOCs. RT-PCR primers and four sloppy molecular beacon (SMB) probes were designed to amplify and detect the SARS-CoV-2 N501Y (A23063T) and E484K (G23012A) mutations and their corresponding wild-type sequences. After RT-PCR, the VOCs were identified by a characteristic T-m of each SMB. Assay optimization and testing was performed with RNA from SARS-CoV-2 USA WA1/2020 (wild type (WT)), B.1.1.7, and B.1.351 variant strains. The assay was then validated using clinical samples. The limit of detection for both the WT and variants was 4 and 10 genomic copies/reaction for the 501- and 484-codon assays, respectively. The assay was 100% sensitive and 100% specific for identifying the N501Y and E484K mutations in cultured virus and in clinical samples, as confirmed by Sanger sequencing. We have developed an RT-PCR melt screening test for the major VOCs that can be used to rapidly screen large numbers of patient samples, providing an early warning for the emergence of these variants and a simple way to track their spread.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available